Acta Pharmaceutica

Sciendo

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Acta Pharmaceutica is an open-access journal published by Sciendo in Poland, publishing in english. It is listed in DOAJ and MEDLINE and PUBMED according to the sources read. Declared publication charge: 1,500 EUR. Declared review time at DOAJ: 20 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Sciendo
ISSN
1330-0075 · 1846-9558
Country
Poland
Languages
english
Access
Open access
Declared publication charge
1,500 EUR
Articles in DOAJ
518
Declared review time
20 weeks
Declared peer-review model
peer_review

Index listings

  • DOAJ · 2007-11-23
  • MEDLINE · 2003-01-01
  • PUBMED · 2011-09-01
Indexing
DOAJ · MEDLINE · PUBMED
APC
1,500 EUR
Declared review time (DOAJ)
20 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

518

Most recent article

3 months ago

Average review time (journal-declared via DOAJ)

20weeks

Works in OpenAlex

864

Last recorded publication year

2025

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

62

i10-index

472

From OpenAlex open data (CC0).

Editorial & policy12
Last DOAJ review date
2026-07-24
Added to DOAJ
2007-11-23
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
Portico
Observed digital preservation (Keepers registry)— snapshot 2026-09-21
Portico
Editorial board
Official page ↗
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
100%
ORCID iDs in current deposits
88%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
Peer-review policy
View policy
Identity & continuity2
Source type
journal
NLM unique ID (PubMed)
9303678
Classification2

Subjects (DOAJ)

Social Sciences: Industries. Land use. Labor: Special industries and trades: Pharmaceutical industry

LCC codes

HD9665-9675

Subject areas

  • Drug Solubulity and Delivery Systems
  • Drug Solubulity and Delivery Systems
  • Advanced Drug Delivery Systems
  • Advanced Drug Delivery Systems
  • Analytical Methods in Pharmaceuticals
  • Analytical Methods in Pharmaceuticals
  • Synthesis and biological activity
  • Synthesis and biological activity
Show all subjects (50)
  • Analytical Chemistry and Chromatography
  • Analytical Chemistry and Chromatography
  • Advancements in Transdermal Drug Delivery
  • Advancements in Transdermal Drug Delivery
  • Synthesis and Biological Evaluation
  • Synthesis and Biological Evaluation
  • Antibiotics Pharmacokinetics and Efficacy
  • Phytochemicals and Antioxidant Activities
  • Antibiotics Pharmacokinetics and Efficacy
  • Phytochemicals and Antioxidant Activities
  • Synthesis and Characterization of Heterocyclic Compounds
  • Synthesis and Characterization of Heterocyclic Compounds
  • Essential Oils and Antimicrobial Activity
  • Essential Oils and Antimicrobial Activity
  • Crystallization and Solubility Studies
  • Crystallization and Solubility Studies
  • Phytochemistry and Biological Activities
  • Phytochemistry and Biological Activities
  • Pharmaceutical studies and practices
  • Multicomponent Synthesis of Heterocycles
  • Multicomponent Synthesis of Heterocycles
  • Pharmaceutical studies and practices
  • Natural product bioactivities and synthesis
  • Natural product bioactivities and synthesis
  • Quinazolinone synthesis and applications
  • Quinazolinone synthesis and applications
  • Natural Antidiabetic Agents Studies
  • Bioactive Compounds and Antitumor Agents
  • Natural Antidiabetic Agents Studies
  • Bioactive Compounds and Antitumor Agents
  • Pharmacological Effects of Natural Compounds
  • Pharmacological Effects of Natural Compounds
  • Protein purification and stability
  • Drug Transport and Resistance Mechanisms
  • Phenothiazines and Benzothiazines Synthesis and Activities
  • Phenothiazines and Benzothiazines Synthesis and Activities
  • Drug Transport and Resistance Mechanisms
  • Cancer therapeutics and mechanisms
  • Cancer therapeutics and mechanisms
  • Protein purification and stability
  • Computational Drug Discovery Methods
  • Computational Drug Discovery Methods

Keywords (DOAJ)

  • biomedicine
  • pharmaceutical and related sciences

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: